Thomas Ransohoff

Thomas Ransohoff
Thomas Ransohoff, M.S., is a highly experienced professional in the biopharmaceutical industry with a strong background in the development and manufacture of biologics. He currently serves as Principal at RTI Consulting, LLC, where he offers strategic consulting services to life sciences firms, and as an Operating Partner at Keensight Capital.
His career includes roles such as Technical Head at National Resilience, Inc., where he led the Biologics Franchise after the acquisition of 4th Dimension Bioprocess, a firm he co-founded and served as COO. Prior to this, Mr. Ransohoff was a Managing Director at BDO and BioProcess Technology Consultants (BPTC), a notable CMC consulting firm he helped establish over two decades.
His expertise extends to various biopharmaceutical companies including TranXenoGen, Dyax, Repligen, and Xoma, where he held senior positions. Additionally, Mr. Ransohoff is recognized for co-founding successful start-ups like 4th Dimension Bioprocess, Tarpon Biosystems, and BioFlash Partners. He also holds multiple board and scientific advisory board positions.